Antibody hinders growth of Gleevec-resistant gastrointestinal tumors in lab tests

An antibody that binds to a molecule on the surface of a rare but deadly tumor of the gastrointestinal tract inhibits the growth of the cancer cells in mice, according to researchers at the Stanford University School of Medicine.

http://medicalxpress.com/news/2013-02-antibody-hinders-growth-gleevec-resistant-gastrointestinal.html